Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Related structures:
AlphaFold database: A4HBJ9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 136 | 140 | PF00656 | 0.404 |
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.291 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.623 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.579 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.551 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.510 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.482 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.547 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.357 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.417 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 9 | 13 | PF00082 | 0.457 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.491 |
DOC_MAPK_gen_1 | 180 | 189 | PF00069 | 0.281 |
DOC_MAPK_gen_1 | 223 | 231 | PF00069 | 0.498 |
DOC_MAPK_MEF2A_6 | 198 | 205 | PF00069 | 0.273 |
DOC_MAPK_RevD_3 | 111 | 127 | PF00069 | 0.332 |
LIG_14-3-3_CanoR_1 | 114 | 123 | PF00244 | 0.531 |
LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.595 |
LIG_14-3-3_CanoR_1 | 90 | 100 | PF00244 | 0.416 |
LIG_BRCT_BRCA1_1 | 61 | 65 | PF00533 | 0.445 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.387 |
LIG_FHA_2 | 134 | 140 | PF00498 | 0.536 |
LIG_FHA_2 | 211 | 217 | PF00498 | 0.455 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.559 |
LIG_LIR_Gen_1 | 20 | 30 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 207 | 215 | PF02991 | 0.458 |
LIG_LIR_Gen_1 | 62 | 70 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 207 | 211 | PF02991 | 0.461 |
LIG_LRP6_Inhibitor_1 | 125 | 131 | PF00058 | 0.277 |
LIG_PCNA_PIPBox_1 | 78 | 87 | PF02747 | 0.427 |
LIG_PDZ_Class_2 | 226 | 231 | PF00595 | 0.628 |
LIG_SH2_CRK | 85 | 89 | PF00017 | 0.273 |
LIG_SH2_STAP1 | 85 | 89 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.290 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.517 |
LIG_TYR_ITIM | 184 | 189 | PF00017 | 0.258 |
LIG_WRC_WIRS_1 | 205 | 210 | PF05994 | 0.279 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.542 |
MOD_CK2_1 | 106 | 112 | PF00069 | 0.504 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.539 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.537 |
MOD_CK2_1 | 210 | 216 | PF00069 | 0.451 |
MOD_CK2_1 | 33 | 39 | PF00069 | 0.569 |
MOD_GlcNHglycan | 188 | 192 | PF01048 | 0.389 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.454 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.437 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.511 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.551 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.464 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.423 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.509 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.448 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.505 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.454 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.518 |
MOD_PIKK_1 | 206 | 212 | PF00454 | 0.397 |
MOD_PKA_1 | 143 | 149 | PF00069 | 0.460 |
MOD_PKA_1 | 167 | 173 | PF00069 | 0.480 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.480 |
MOD_PKB_1 | 149 | 157 | PF00069 | 0.341 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.515 |
MOD_Plk_1 | 187 | 193 | PF00069 | 0.370 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.433 |
MOD_Plk_2-3 | 106 | 112 | PF00069 | 0.561 |
MOD_Plk_2-3 | 133 | 139 | PF00069 | 0.493 |
MOD_Plk_2-3 | 39 | 45 | PF00069 | 0.286 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.585 |
MOD_SUMO_for_1 | 171 | 174 | PF00179 | 0.288 |
MOD_SUMO_rev_2 | 154 | 160 | PF00179 | 0.610 |
MOD_SUMO_rev_2 | 176 | 184 | PF00179 | 0.532 |
MOD_SUMO_rev_2 | 95 | 103 | PF00179 | 0.493 |
TRG_DiLeu_BaEn_1 | 112 | 117 | PF01217 | 0.489 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.473 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.443 |
TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.292 |
TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.337 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.372 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4S1 | Leptomonas seymouri | 31% | 97% |
A0A0N1PD85 | Leptomonas seymouri | 47% | 100% |
A0A1X0NXA6 | Trypanosomatidae | 27% | 76% |
A0A1X0NXA8 | Trypanosomatidae | 36% | 99% |
A0A3Q8IKU7 | Leishmania donovani | 55% | 100% |
A0A3S5H792 | Leishmania donovani | 34% | 94% |
A0A422MZP2 | Trypanosoma rangeli | 25% | 76% |
A4HBK0 | Leishmania braziliensis | 31% | 95% |
A4HZL5 | Leishmania infantum | 34% | 94% |
A4HZL6 | Leishmania infantum | 55% | 100% |
E9AUW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 100% |
E9AUW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 94% |
Q4QCL3 | Leishmania major | 34% | 100% |
Q4QCL4 | Leishmania major | 54% | 100% |
V5BG41 | Trypanosoma cruzi | 33% | 99% |
V5BKK3 | Trypanosoma cruzi | 25% | 76% |